Back to Search
MICHAEL HEJNA, M.D., PHD.
M.D., PHD.
Orthopaedic Surgery Physician
NPI: 1013913573IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
OTHER
Class of 1990
Research & Publications (20)
[Neoadjuvant therapy for resectable esophageal cancer].
PMID 16220454·Z Gastroenterol·2005
4-observational
[Acceptance of and satisfaction with medical information provided to cancer patients].
PMID 11388081·Wien Klin Wochenschr·2001
8-other
Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001.
PMID 18418220·Anticancer Drugs·2008
3-trial
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma.
PMID 18838713·J Clin Oncol·2008
8-other
Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
PMID 16549831·J Clin Oncol·2006
3-trial
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable.
PMID 16940978·Br J Cancer·2006
4-observational
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.
PMID 15864644·J Cancer Res Clin Oncol·2005
4-observational
Endoscopic ultrasound guided therapy of benign and malignant biliary obstruction: a case series.
PMID 16086710·Am J Gastroenterol·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 353 E BURLINGTON ST, STE 100
RIVERSIDE, IL 60546 - Phone
- (708) 442-0221
Quick Facts
- NPI
- 1013913573
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile